Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
290.65-9.01 (-3.01%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close299.66
Bid289.00 x 200
Ask305.00 x 100
Day's Range289.78 - 300.32
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap63.69B
P/E Ratio (ttm)16.98
Avg Vol (3m)1,568,714
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals4 hours ago

    Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week

    Earnings season for our Massachusetts biotech giants kicks off this week when Vertex Pharmaceuticals reports its third quarter financials on Tuesday evening, followed by Biogen on Wednesday morning. While probably just a fluke, it’s unusual for Vertex (VRTX) to be the first local biotech to give a quarterly update, as that honor usually goes to Biogen (BIIB). Vertex : To some extent, the financial news expected from the Boston-based company is already old news.

  • 24/7 Wall St.12 hours ago

    Top Health Care Earnings Coming Next Week

    Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.

  • GlobeNewswire2 days ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit – BIIB

    NEW YORK, Oct. 21, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Biogen Inc. between July 23, 2014 ...